Corrigendum: Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer (Annals of Oncology (2018) 29 (i28–i37) (DOI: 10.1093/annonc/mdx705)

C. Ricordel, L. Friboulet, F. Facchinetti, J. C. Soria

    Résultats de recherche: Contribution à un journal!!Comment/debate

    15 Citations (Scopus)

    Résumé

    In the original article, the sentence "Occurrence of grade 3 and 4 interstitial lung disease has been reported in 38% (13/34) of patients exposed to the combination of osimertinib plus durvalumab [73], . . ." Has been corrected to "Occurrence of interstitial lung disease has been reported in 38% (13/34) of patients exposed to the combination of osimertinib plus durvalumab, of which five were of grade 3 and 4 [73], . . .".

    langue originaleAnglais
    Numéro d'articlemdy222
    Pages (de - à)858
    Nombre de pages1
    journalAnnals of Oncology
    Volume30
    Numéro de publication5
    Les DOIs
    étatPublié - 1 mai 2019

    Contient cette citation